Journal
CRITICAL CARE MEDICINE
Volume 28, Issue 6, Pages 1754-1759Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00003246-200006000-00009
Keywords
piperacillin; interstitium; intensive care; pharmacokinetics; human; cardiac surgery; in vivo; microdialysis; distribution; target site
Categories
Ask authors/readers for more resources
Objective: Therapeutic failure of antibiotic therapy has been ascribed to pharmacokinetic alterations in compromised patient populations. The present study, therefore, aimed at examining the influences of cardiac surgery and intensive care procedures on the postoperative target site distribution of piperacillin. For this purpose, the penetration of piperacillin to the interstitial space fluid, the relevant target site for most bacterial infections, was compared between patients after aortic valve replacement and healthy volunteers. Design: Comparative study in two study populations. Setting: The intensive care unit and research ward of a university hospital. Patients: The study population included six otherwise healthy patients scheduled to undergo aortic valve replacement and a control group of six healthy male volunteers. Interventions: After the administration of a single iv infusion of 4.0 g piperacillin, free piperacillin concentrations were measured in the interstitium of skeletal muscle and subcutaneous tissue by in vivo microdialysis and in venous serum. Piperacillin concentrations were assayed with reversed phase high-performance liquid chromatography. Measurements and Main Results: Interstitial piperacillin concentrations in muscle and subcutaneous adipose tissue were significantly lower in patients compared with volunteers with the area under the curve for the interstitium/area under the curve for serum concentration ratios ranging from 0.25 to 0.27 and from 0.43 to 1.22 in patients and volunteers, respectively (p < .05 between groups). The terminal elimination half-life was markedly prolonged in patients, leading to a concomitant increase in t > minimal inhibitory concentration (MIC) values, the relevant surrogate for therapeutic success of therapy with beta-lactam antibiotics, for strains with MIG(50) <4 mu g/mL. For strains with MIC50 >20 mu l/mL, however, inadequate target site concentrations were attained in the patient population. Conclusions: During the postoperative and intensive care periods, target site concentrations of piperacillin are markedly altered and decreased. This may also be true for other antibiotic agents and may have clinical implications in that current dosing guidelines may result in inadequate target site concentrations for high-MIG strains. Conceivably, this could lead to therapeutic failure in some patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available